Issues in Diagnosis and Treatment of Type 1 Diabetes Mellitus in Childhood — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Issues in Diagnosis and Treatment of Type 1 Diabetes Mellitus in Childhood
Post-Graduate School of Paediatrics, Departments of Medical and Surgical Sciences of Mothers, Children and Adults, University of Modena & Reggio Emilia, Paediatric Unit, Modena, Italy
,
Post-Graduate School of Paediatrics, Departments of Medical and Surgical Sciences of Mothers, Children and Adults, University of Modena & Reggio Emilia, Paediatric Unit, Modena, Italy
1 Post-Graduate School of Paediatrics, Departments of Medical and Surgical Sciences of Mothers, Children and Adults, University of Modena & Reggio Emilia, Paediatric Unit, Modena, Italy
2 Post-Graduate School of Paediatrics, Departments of Medical and Surgical Sciences of Mothers, Children and Adults, University of Modena & Reggio Emilia, Paediatric Unit, Modena, Italy
Type 1 Diabetes Mellitus remains one of the most complex chronic diseases in childhood. Although advances in knowledge and technology, as the use of insulin pumps or glucose sensors, have improved the quality of life of patients, the onset of the disease, as well as long-term treatment and diet, are pitfalls for families and clinicians. It is important to bear in mind that acute, life-threatening consequences of uncontrolled diabetes are hyperglycemia with ketoacidosis, both in new diagnosis and in patients already on treatment, and may be hidden by other symptoms. Moreover, treatment with insulin and diet should always be tailored on lifestyle habits and age of the patient. Aim of this work is to briefly summarise and comment what are the worst insidious aspects of Diabetes and what are the best strategies to improve the management of the disease in childhood.
American Diabetes Association (2007) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 30, S42-S47. http://dx.doi.org/10.2337/dc07-S042
Erlich, H., Valdes, A.M., Noble, J., Carlson, J.A., Varney, M., Concannon, P., Mychaleckyj, J.C., Todd, J.A., Bonella, P., Fear, A.L., Lavant, E., Louey, A. and Moonsamy, P. (2008) Type 1 Diabetes Genetics Consortium. HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk: Analysis of the Type 1 Diabetes Genetics Consortium Families. Diabetes, 57, 1084-1092. http://dx.doi.org/10.2337/db07-1331
Lambert, A.P., Gillespie, K.M., Thomson, G., Cordell, H.J., Todd, J.A., Gale, E.A. and Bingley, P.J. (2004) Absolute Risk of Childhood-Onset Type 1 Diabetes Defined by Human Leukocyte Antigen Class II Genotype: A Population-Based Study in the United Kingdom. Journal of Clinical Endocrinology and Metabolism, 89, 4037-4043. http://dx.doi.org/10.1210/jc.2003-032084
Sabbah, E., Savola, K., Ebeling, T., Kulmala, P., Vahasalo, P., Ilonen, J., Salmela, P.I. and Knip, M. (2000) Genetic, Autoimmune, and Clinical Characteristics of Childhood and Adult-Onset Type 1 Diabetes. Diabetes Care, 23, 1326-1332. http://dx.doi.org/10.2337/diacare.23.9.1326
Verge, C.F., Stenger, D., Bonifacio, E., Colman, P.G., Pilcher, C., Bingley, P.J. and Eisenbarth, G.S. (1998) Combined Use of Autoantibodies (IA-2 Autoantibody, GAD Autoantibody, Insulin Autoantibody, Cytoplasmic Islet Cell Antibodies) in Type 1 Diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes, 47, 1857-1866. http://dx.doi.org/10.2337/diabetes.47.12.1857
Skyler, J.S., Krischer, J.P., Wolfsdorf, J., Cowie, C., Palmer, J.P., Greenbaum, C., Cuthbertson, D., Rafkin-Mervis, L.E., Chase, H.P. and Leschek, E. (2005) Effects of Oral Insulin in Relatives of Patients with Type 1 Diabetes: The Diabetes Prevention Trial—Type 1. Diabetes Care, 28, 1068-1076. http://dx.doi.org/10.2337/diacare.28.5.1068
Verge, C.F., Gianani, R., Kawasaki, E., Yu, L., Pietropaolo, M., Jackson, R.A., Chase, H.P. and Eisenbarth, G.S. (1996) Prediction of Type 1 Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512-bdc/IA-2 Autoantibodies. Diabetes, 45, 926-933. http://dx.doi.org/10.2337/diab.45.7.926
Dotta, F., Censini, S., van Halteren, A.G., Marselli, L., Masini, M., Dionisi, S., Mosca, F., Boggi, U., Muda, A.O., Del Prato, S., Elliott, J.F., Covacci, A., Rappuoli, R., Roep, B.O. and Marchetti, P. (2007) Coxsackie B4 Virus Infection of Beta Cells and Natural Killer Cell Insulitis in Recent-Onset Type 1 Diabetic Patients. Proceedings of the National Academy of Sciences of the United States of America, 104, 5115-5120. http://dx.doi.org/10.1073/pnas.0700442104
Richardson, S.J., Willcox, A., Bone, A.J., Foulis, A.K. and Morgan, N.G. (2009) The Prevalence of Enteroviral Capsid Protein Vp1 Immunostaining in Pancreatic Islets in Human Type 1 Diabetes. Diabetologia, 52, 1143-1151. http://dx.doi.org/10.1007/s00125-009-1276-0
Majaliwa, E.S., Elusiyan, B.E., Adesiyun, O.O., Laigong, P., Adeniran, A.K., Kandi, C.M., Yarhere, I., Limbe, S.M. and Iughetti, L. (2008) Type 1 Diabetes Mellitus in the African Population: Epidemiology and Management Challenges. Acta Biomedica, 79, 255-259.
EURODIAB ACE Study Group (2000) Variation and Trends in Incidence of Childhood Diabetes in Europe. The Lancet, 355, 873-876. http://dx.doi.org/10.1016/S0140-6736(99)07125-1
Bruno, G., Maule, M., Merletti, F., Novelli, G., Falorni, A., Iannilli, A., Iughetti, L., Altobelli, E., d’Annunzio, G., Piffer, S., Pozzilli, P., Iafusco, D., Songini, M., Roncarolo, F., Toni, S., Carle, F. and Cherubini,V., RIDI Study Group (2010) Age-Period-Cohort Analysis of 1990-2003 Incidence Time Trends of Childhood Diabetes in Italy: The Ridi Study. Diabetes, 59, 2281-2287. http://dx.doi.org/10.2337/db10-0151
International Society for Paediatric and Adolescent Diabetes (2009) Clinical Practice Consensus Guidelines 2009 Compendium. Phases of Diabetes in Children and Adolescents. Pediatric Diabetes, 10, 13-16.
Bober, E., Dundar, B. and Buyukgebiz, A. (2001) Partial Remission Phase and Metabolic Control in Type 1 Diabetes Mellitus in Children and Adolescents. Journal of Pediatric Endocrinology and Metabolism, 14, 435-441. http://dx.doi.org/10.1515/jpem.2001.14.4.435
The Diabetes Control and Complications Trial Research Group (1998) Effect of Intensive Therapy on Residual Beta-Cell Function in Patients with Type Diabetes in the Diabetes Control and Complications Trial. A Randomized, Controlled Trial. Annals of Internal Medicine, 128, 517-523. http://dx.doi.org/10.7326/0003-4819-128-7-199804010-00001
Wolfsdorf, J., Glaser, N. and Sperling, M.A. (2006) Diabetic Ketoacidosis in Infants, Children, and Adolescents: A Consensus Statement from the American Diabetes Association. Diabetes Care, 29, 1150-1159. http://dx.doi.org/10.2337/dc06-9909
Wolfsdorf, J., Craig, M.E., Daneman, D., Dunger, D., Edge, J., Lee, W., Rosenbloom, A., Sperling, M. and Hanas, R. (2009) Diabetic Ketoacidosis in Children and Adolescents with Diabetes. Pediatric Diabetes, 10, 118-133.
Foster, D.W. and McGarry, J.D. (1983) The Metabolic Derangements and Treatment of Diabetic Ketoacidosis. The New England Journal of Medicine, 309, 159-169. http://dx.doi.org/10.1056/NEJM198307213090307
Kitabchi, A.E., Umpierrez, G.E., Murphy, M.B. and Kreisberg, R.A. (2006) Hyperglycemic Crises in Adult Patients with Diabetes: A Consensus Statement from the American Diabetes Association. Diabetes Care, 29, 2739-2748. http://dx.doi.org/10.2337/dc06-9916
Hanas, R., Lindgren, F. and Lindblad, B. (2009) A 2-yr National Population Study of Pediatric Ketoacidosis in Sweden: Predisposing Conditions and Insulin Pump Use. Pediatric Diabetes, 10, 33-37. http://dx.doi.org/10.1111/j.1399-5448.2008.00441.x
Chase, H.P., Garg, S.K. and Jelley, D.H. (1990) Diabetic Ketoacidosis in Children and the Role of Outpatient Management. Pediatrics in Review, 11, 297-304. http://dx.doi.org/10.1542/pir.11-10-297
Linares, M.Y., Schunk, J.E. and Lindsay, R. (1996) Laboratory Presentation in Diabetic Ketoacidosis and Duration of Therapy. Pediatric Emergency Care, 12, 347-351. http://dx.doi.org/10.1097/00006565-199610000-00006
Koves, I.H., Neutze, J., Donath, S., Lee, W., Werther, G.A., Barnett, P. and Cameron, F.J. (2004) The Accuracy of Clinical Assessment of Dehydration during Diabetic Ketoacidosis in Childhood. Diabetes Care, 27, 2485-2487. http://dx.doi.org/10.2337/diacare.27.10.2485
Harris, G.D. and Fiordalisi, I. (1994) Physiologic Management of Diabetic Ketoacidemia. A 5-Year Prospective Pediatric Experience in 231 Episodes. Archives of Pediatrics and Adolescent Medicine, 148, 1046-1052. http://dx.doi.org/10.1001/archpedi.1994.02170100044009
Katz, M.A. (1973) Hyperglycemia-Induced Hyponatremia-Calculation of Expected Serum Sodium Depression. The New England Journal of Medicine, 289, 843-844. http://dx.doi.org/10.1056/NEJM197310182891607
Hillier, T.A., Abbott, R.D. and Barrett, E.J. (1999) Hyponatremia: Evaluating the Correction Factor for Hyperglycemia. The American Journal of Medicine, 106, 399-403. http://dx.doi.org/10.1016/S0002-9343(99)00055-8
Kitabchi, A.E. (1989) Low-Dose Insulin Therapy in Diabetic Ketoacidosis: Fact or Fiction? Diabetes/Metabolism Research and Reviews, 5, 337-363. http://dx.doi.org/10.1002/dmr.5610050403
Edge, J.A., Jakes, R.W., Roy, Y., Hawkins, M., Winter, D., Ford-Adams, M.E., Murphy, N.P., Bergomi, A., Widmer, B. and Dunger, D.B. (2006) The UK Case-Control Study of Cerebral Oedema Complicating Diabetic Ketoacidosis in Children. Diabetologia, 49, 2002-2009. http://dx.doi.org/10.1007/s00125-006-0363-8
Adrogue, H.J., Lederer, E.D., Suki, W.N. and Eknoyan, G. (1986) Determinants of Plasma Potassium Levels in Diabetic Ketoacidosis. Medicine (Baltimore), 65, 163-172. http://dx.doi.org/10.1097/00005792-198605000-00004
Defronzo, R.A., Felig, P., Ferrannini, E. and Wahren, J. (1980) Effect of Graded Doses of Insulin on Splanchnic and Peripheral Potassium Metabolism in Man. American Journal of Physiology, 238, E421-E427.
Assal, J.P., Aoki, T.T., Manzano, F.M. and Kozak, G.P. (1974) Metabolic Effects of Sodium Bicarbonate Inmanagement of Diabetic Ketoacidosis. Diabetes, 23, 405-411. http://dx.doi.org/10.2337/diab.23.5.405
Soler, N.G., Bennett, M.A., Dixon, K., Fitzgerald, M.G. and Malinis, J.M. (1972) Potassium Balance during Treatment of Diabetic Ketoacidosis with Special Reference to the Use of Bicarbonate. The Lancet, 30, 665-667. http://dx.doi.org/10.1016/S0140-6736(72)92083-1
Narins, R.G. and Cohen, J.J. (1987) Bicarbonate Therapy for Organic Acidosis: The Case for Its Continued Use. Annals of Internal Medicine, 106, 615-618. http://dx.doi.org/10.7326/0003-4819-106-4-615
Edge, J.A. (2000) Cerebral Oedema during Treatment of Diabetic Ketoacidosis: Are We Any Nearer Finding a Cause? Diabetes/Metabolism Research and Reviews, 16, 316-324. http://dx.doi.org/10.1002/1520-7560(2000)9999:9999 3.0.CO;2-R
Muir, A.B., Quisling, R.G., Yang, M.C. and Rosenbloom, A.L. (2004) Cerebral Edema in Childhood Diabetic Ketoacidosis: Natural History, Radiographic Findings, and Early Identification. Diabetes Care, 27, 1541-1546. http://dx.doi.org/10.2337/diacare.27.7.1541
Bangstad, H.J., Danne, T., Deeb, L., Jarosz-Chobot, P., Urakami, T. and Hanas, R. (2009) Insulin Treatment in Children and Adolescents with Diabetes. Pediatric Diabetes, 10, 82-99.
National Collaborating Centre for Women’s and Children’s Health (2004) Type 1 Diabetes: Diagnosis and Management of Type 1 Diabetes in Children and Young People. RCOG Press, London.
American Diabetes Association (2003) Nutrition Principles and Recommendations in Diabetes (Position Statement). Diabetes Care, 27, S36-S46.
Smart, C., Aslander-van, V.E. and Waldron, S. (2009) Nutritional Management in Children and Adolescents with Diabetes. Pediatric Diabetes, 10, 100-117.
Gillespie, S.J., Kulkarni, K.D. and Daly, A.E. (1998) Using Carbohydrate Counting in Diabetes Clinical Practice. Journal of the American Dietetic Association, 98, 897-905. http://dx.doi.org/10.1016/S0002-8223(98)00206-5
Gilbertson, H.R., Brand-Miller, J.C., Thorburn, A.W., Evans, S., Chondros, P. and Werther, G.A. (2001) The Effect of Flexible Low Glycemic Index Dietary Advice versus Measured Carbohydrate Exchange Diets on Glycemic Control in Children with Type 1 Diabetes. Diabetes Care, 24, 1137-1143. http://dx.doi.org/10.2337/diacare.24.7.1137